Sharps Technology Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
STSS Nasdaq 3841 https://sharpstechnology.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Sharps Technology Inc

Sharps Technology, Inc. and BullFrog AI Holdings, Inc. Interviews to Air on Bloomberg TV on the RedChip Money Report(R) - May 19th, 2023 1:00 pm
We Might See A Profit From Sharps Technology, Inc. (NASDAQ:STSS) Soon - May 6th, 2023 2:18 pm
BullFrog AI and Sharps Technology Interviews to Air on Bloomberg U.S. on the RedChip Money Report(R) - Apr 5th, 2023 11:05 am
Sharps Technology Issues Update Letter to Shareholders from CEO Robert Hayes - Apr 4th, 2023 12:00 pm
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? - Mar 1st, 2023 2:40 pm
With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO - Feb 15th, 2023 2:55 pm
Sharps Technology Appoints Justin Page as Vice President of Technical Operations - Feb 9th, 2023 2:21 pm
Aegis Capital Corp. Acted as Exclusive Placement Agent on a $3.8 Million Private Placement for Sharps Technology, Inc. (NASDAQ:STSS) - Feb 6th, 2023 2:50 pm
Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market - Feb 6th, 2023 2:02 pm
Sharps Technology Announces Pricing of $3.8 Million Private Placement Priced at the Market - Feb 1st, 2023 2:20 pm
Sharps Technology Ships First Containers of Safety Syringes to Nephron Pharmaceuticals for Commercialization - Jan 31st, 2023 1:00 pm
STSS: Drug delivery medical device company with a strong line of specialty safety syringe products signs strategic partnership with Nephron Pharmaceuticals that positions the company for strong revenue growth in 2023. - Jan 30th, 2023 11:00 am
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products - Jan 17th, 2023 3:00 pm
Global Drug Delivery Systems Market Size Projected to Reach $71.75 Billion By 2029 - Jan 12th, 2023 5:51 pm
Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry - Jan 12th, 2023 2:25 pm
Sharps Technology Inc. to Introduce New Specialized Prefillable Syringe Systems in 2023 - Jan 10th, 2023 1:00 pm
Great news for Sharps Technology, Inc. (NASDAQ:STSS): Insiders acquired stock in large numbers last year - Jan 4th, 2023 1:13 pm
Sharps Technology Begins Manufacturing at its Hungary Facility for the Company's Innovative Syringe Products - Dec 20th, 2022 1:00 pm
Sharps Technology and Nephron Pharmaceuticals Sign Distribution Agreement for its Innovative Syringe Products - Dec 13th, 2022 1:00 pm
Breakeven Is Near for Sharps Technology, Inc. (NASDAQ:STSS) - Nov 24th, 2022 11:08 am